Michel Vounatsos - Feb 10, 2022 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Chief Executive Officer, Director
Signature
/s/ Wendell Taylor, attorney-in-fact for Michel Vounatsos
Stock symbol
BIIB
Transactions as of
Feb 10, 2022
Transactions value $
$0
Form type
4
Date filed
2/14/2022, 03:15 PM
Previous filing
Jan 21, 2022
Next filing
Feb 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BIIB Common Stock 63.7K Feb 10, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Award $0 +28.4K $0.00 28.4K Feb 10, 2022 Common Stock 28.4K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022.